These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28874848)

  • 1. Suppressive drug combinations and their potential to combat antibiotic resistance.
    Singh N; Yeh PJ
    J Antibiot (Tokyo); 2017 Nov; 70(11):1033-1042. PubMed ID: 28874848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When more is less: Emergent suppressive interactions in three-drug combinations.
    Beppler C; Tekin E; White C; Mao Z; Miller JH; Damoiseaux R; Savage VM; Yeh PJ
    BMC Microbiol; 2017 May; 17(1):107. PubMed ID: 28477626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction.
    Coates ARM; Hu Y; Holt J; Yeh P
    Expert Rev Anti Infect Ther; 2020 Jan; 18(1):5-15. PubMed ID: 31847614
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug combinations: a strategy to extend the life of antibiotics in the 21st century.
    Tyers M; Wright GD
    Nat Rev Microbiol; 2019 Mar; 17(3):141-155. PubMed ID: 30683887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy between novel antimicrobials and conventional antibiotics or bacteriocins.
    Wolska KI; Grześ K; Kurek A
    Pol J Microbiol; 2012; 61(2):95-104. PubMed ID: 23163208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counteracting antibiotic resistance: breaking barriers among antibacterial strategies.
    Baquero F; Coque TM; Cantón R
    Expert Opin Ther Targets; 2014 Aug; 18(8):851-61. PubMed ID: 24881465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
    Hickman RA; Hughes D; Cars T; Malmberg C; Cars O
    Clin Microbiol Infect; 2014 Apr; 20(4):O267-73. PubMed ID: 24118201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interactions modulate the potential for evolution of resistance.
    Michel JB; Yeh PJ; Chait R; Moellering RC; Kishony R
    Proc Natl Acad Sci U S A; 2008 Sep; 105(39):14918-23. PubMed ID: 18815368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic strategies against autophagic escape by pathogenic bacteria.
    Sharma S; Tiwari M; Tiwari V
    Drug Discov Today; 2021 Mar; 26(3):704-712. PubMed ID: 33301978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic interactions in two-drug and three-drug combinations (thymol, EDTA and vancomycin) against multi drug resistant bacteria including E. coli.
    Hamoud R; Zimmermann S; Reichling J; Wink M
    Phytomedicine; 2014 Mar; 21(4):443-7. PubMed ID: 24262063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination therapy against multidrug-resistant bacteria].
    Araoka H
    Nihon Rinsho; 2012 Feb; 70(2):305-10. PubMed ID: 22413536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antibacterial activity of the combination of the alkaloid sanguinarine with EDTA and the antibiotic streptomycin against multidrug resistant bacteria.
    Hamoud R; Reichling J; Wink M
    J Pharm Pharmacol; 2015 Feb; 67(2):264-73. PubMed ID: 25495516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annual trends in antibiotic resistance of nosocomial Acinetobacter baumannii strains and the effect of synergistic antibiotic combinations.
    Tatman-Otkun M; Gürcan S; Ozer B; Shokrylanbaran N
    New Microbiol; 2004 Jan; 27(1):21-8. PubMed ID: 14964402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction into antibiotic combination treatment.
    Ellorhaoui M
    Ther Hung; 1978; 26(1):3-11. PubMed ID: 663873
    [No Abstract]   [Full Text] [Related]  

  • 16. The antibiotic resistome.
    Wright GD
    Expert Opin Drug Discov; 2010 Aug; 5(8):779-88. PubMed ID: 22827799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of antibiotic combinations].
    Régnier B
    Presse Med; 1987 Dec; 16(43):2186-91. PubMed ID: 2963313
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibacterial activity of benzydamine and antibiotic-benzydamine combinations against multifold resistant clinical isolates.
    Fanaki NH; El-Nakeeb MA
    Arzneimittelforschung; 1996 Mar; 46(3):320-3. PubMed ID: 8901158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New strategies for combating multidrug-resistant bacteria.
    Wright GD; Sutherland AD
    Trends Mol Med; 2007 Jun; 13(6):260-7. PubMed ID: 17493872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.